Saturday 17 October 2026
Export AIMD’s income statement to Excel — free account
Ainos, Inc.
AIMD Technology Scientific & Technical Instruments
Ainos, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $124,200.00, up 500.0% from fiscal 2024. In the quarter to June 2026, revenue fell 95.7%, EPS grew 37.4%, free cash flow fell 8.30% and total debt fell 25.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.94
0.02
−2.08%
Follow AIMD
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1,041.79 | 460.69 | 56.40 | 118.10 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(9.85) | (8.53) | (8.19) | (13.34) | |
P/B ratio |
4.35 | 1.47 | 0.93 | 1.57 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1,667.86 | 854.02 | 149.65 | 199.36 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(5.11) | (3.55) | (4.03) | (5.77) | |
EV/FCF |
(5.07) | (3.53) | (3.98) | (5.70) | |
Quick Ratio |
0.09 | 0.45 | 0.39 | 1.94 | |
Current Ratio |
0.13 | 0.55 | 1.06 | 2.96 | |
Net Debt/EBITDA |
0.44 | (5.55) | (3.42) | (6.26) | |
Debt/Assets |
0.00% | 40.76% | 52.70% | 48.50% | |
Debt/Equity |
0.00 | 1.58 | 1.45 | 1.10 | |
Asset Turnover |
0.00 | 0.00 | 0.01 | 0.01 | |
Operating CF/Net income |
0.32 | 0.40 | 0.19 | 0.40 | |
Capex/Depreciation |
0.00 | (0.01) | 0.00 | (0.01) | |
Interest Coverage |
(21.97) | (12.91) | (24.29) | (15.77) | |
Research and Development Expense of Revenue |
925,200.00% | 844,950.00% | 19,128.83% | 90,481.82% | |
Selling, General and Administrative Expense of Revenue |
1,274,400.00% | 296,600.00% | 19,674.77% | 36,150.00% | |
Intangible Assets out of Total Assets |
0.87 | 0.82 | 0.92 | 0.90 | |
Share Based Compensation of Revenue |
1,006,300.00% | 0.00% | 16,516.22% | 15,836.36% | |
Graham Net Nets |
(0.99) | (1.53) | (1.74) | (0.69) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(129.90%) | (207.91%) | (215.24%) | (114.70%) | |
Free Cash Flow Yield |
(31.61%) | (52.47%) | (66.64%) | (29.61%) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.20) | (0.16) | (0.20) | (0.26) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.20) | (0.16) | (0.20) | (0.26) | |
Cash per Share |
0.19 | 0.47 | 0.10 | 0.25 | |
Shareholders Equity per Share |
0.45 | 0.94 | 1.77 | 2.21 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.45 | 0.94 | 1.77 | 2.21 | |
Free Cash Flow |
(1.45) | (0.99) | (0.85) | (1.19) | |
Working Capital |
(14.09) | (2.83) | 0.06 | 1.14 | |
Capital Expenditures |
(0.01) | (0.01) | 0.00 | (0.01) | |
Net Current Asset Value |
(14.09) | (12.87) | (12.17) | (10.91) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
29.00 | 34.00 | (0.14) | 4.59 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
— | 0.00 | 0.00 | 0.00 | |
Average Inventory |
0.23 | 0.23 | 0.22 | 0.16 | |
Average Assets |
21.74 | 24.22 | 24.85 | 27.02 | |
Average Common Equity |
7.36 | 9.41 | 11.54 | 14.03 |
Columns are period end dates